21

Soma MR, Pagliarini P, Butti G, Paoletti R, Paoletti P, Fumagalli R
Simvastatin, an inhibitor of cholesterol biosynthesis, shows a synergistic effect with N,N'-bis(2-chloroethyl)-N-nitrosourea and beta-interferon on human glioma cells
Cancer Res 1992 Aug 15;52(16):4348-55 (Cell Culture Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1643632&dopt=Abstract

22

Loo TW, Clarke DM
Blockage of drug resistance in vitro by disulfiram, a drug used to treat alcoholism
J Natl Cancer Inst 2000 Jun 7;92(11):898-902 (Cell Culture Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10841824&dopt=Abstract

23

Browder T, Butterfield CE, Kraling BM, Shi B, Marshall B, O'Reilly MS, Folkman J
Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer
Cancer Res 2000 Apr 1;60(7):1878-86 (Animal Study, Abstract | Full Text)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10766175&dopt=Abstract
Free full text article at:  http://www.ncbi.nlm.nih.gov/entrez/utils/fref.fcgi?
http://cancerres.aacrjournals.org/cgi/pmidlookup?view=full&pmid=10766175

24

Man S, Bocci G, Francia G, Green SK, Jothy S, Hanahan D, Bohlen P, Hicklin DJ, Bergers G, Kerbel RS
Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water
Cancer Res 2002 May 15;62(10):2731-5 (Animal Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12019144&dopt=Abstract

25

Colleoni M, Rocca A, Sandri MT, Zorzino L, Masci G, Nole F, Peruzzotti G, Robertson C, Orlando L, Cinieri S, de BF, Viale G, Goldhirsch A
Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels
Ann Oncol 2002 Jan;13(1):73-80 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11863115&dopt=Abstract

26

27

Wen PY, Alexander E 3rd, Black PM, Fine HA, Riese N, Levin JM, Coleman CN, Loeffler JS
Long term results of stereotactic brachytherapy used in the initial treatment of patients with glioblastomas
Cancer 1994 Jun 15;73(12):3029-36 Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8200000&dopt=Abstract

28

29

Laperriere NJ, Leung PM, McKenzie S, Milosevic M, Wong S, Glen J, Pintilie M, Bernstein M
Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma
Int J Radiat Oncol Biol Phys 1998 Jul 15;41(5):1005-11 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9719109&dopt=Abstract

30

Selker RG, Shapiro WR, Burger P, Blackwood MS, Arena VC, Gilder JC, Malkin MG, Mealey JJ Jr, Neal JH, Olson J, Robertson JT, Barnett GH, Bloomfield S, Albright R, Hochberg FH, Hiesiger E, Green S; Brain Tumor Cooperative Group
The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine
Neurosurgery 2002 Aug;51(2):343-55 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12182772&dopt=Abstract

31

Halligan JB, Stelzer KJ, Rostomily RC, Spence AM, Griffin TW, Berger MS.
Operation and permanent low activity 125I brachytheraphy for recurrent high-grade astrocytomas
Int J Radiat Oncol Biol Phys 1996 Jun 1;35(3):541-7 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8655378&dopt=Abstract

32

Patel S, Breneman JC, Warnick RE, Albright RE Jr, Tobler WD, van Loveren HR, Tew JM Jr
Permanent iodine-125 interstitial implants for the treatment of recurrent glioblastoma multiforme
Neurosurgery 2000 May;46(5):1123-8 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10807244&dopt=Abstract

33

Fernandez PM, Zamorano L, Yakar D, Gaspar L, Warmelink C.
Permanent iodine-125 implants in the up-front treatment of malignant gliomas
Neurosurgery 1995 Mar;36(3):467-73 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7753345&dopt=Abstract

34

35

Lederman G, Arbit E, Odaimi M, Lombardi E, Wrzolek M, Wronski M
Fractionated stereotactic radiosurgery and concurrent taxol in recurrent glioblastoma multiforme: a preliminary report
Int J Radiat Oncol Biol Phys 1998 Feb 1;40(3):661-6 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9486617&dopt=Abstract

36

Lederman G, Wronski M, Arbit E, Odaimi M, Wertheim S, Lombardi E, Wrzolek M
Treatment of recurrent glioblastoma multiforme using fractionated stereotactic radiosurgery and concurrent paclitaxel
Am J Clin Oncol 2000 Apr;23(2):155-9 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10776976&dopt=Abstract

37

Kondziolka D, Flickinger JC, Bissonette DJ, Bozik M, Lunsford LD
Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms
Neurosurgery 1997 Oct;41(4):776-83 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9316038&dopt=Abstract

Nwokedi EC, DiBiase SJ, Jabbour S, Herman J, Amin P, Chin LS
Gamma knife stereotactic radiosurgery for patients with glioblastoma multiforme
Neurosurgery 2002 Jan;50(1):41-6 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11844233&dopt=Abstract

I. Cokgor, G. Akabani, A. Friedman, R. Coleman, M. Zalutsky, R. McLendon, S. Bigner, Z. Xiao-Guang, C. Pegram, C. Wikstrand, J. Herndon, J. Provenzale, H. Friedman, D. Bigner
Results of a Phase II Trial in the Treatment of Recurrent Patients with Brain Tumors Treated with Iodine 131 Anti-Tenascin Monoclonal Antibody 81C6 Via Surgically Created Resection Cavities
ASCO Proceedings, 2000 Annual Meeting, Abstract No. 628 (Clinical Study)
Source: http://www.asco.org/asco/ascoMainConstructor
/1,1003,_12-002324-00_29-00A-00_18-002000-00_19-00137,00.asp

Reardon DA, Akabani G, Coleman RE, Friedman AH, Friedman HS, Herndon JE 2nd, Cokgor I, McLendon RE, Pegram CN, Provenzale JM, Quinn JA, Rich JN, Regalado LV, Sampson JH, Shafman TD, Wikstrand CJ, Wong TZ, Zhao XG, Zalutsky MR, Bigner DD
Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas
J Clin Oncol 2002 Mar 1;20(5):1389-97 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11870184&dopt=Abstract